COVID-19 in Musculoskeletal Oncology


Dear Colleagues and Friends,

In these extraordinary times, we all still strive after achieving the optimal care for our cancer patients. Some of our colleagues have already published articles considering treatment of bone and soft tissue sarcoma patients during the COVID-19 pandemic. The following links may aid decision making at your institutions, further encouraging us to treat our patients in high need of urgent, professional and safe care.

Please feel free to contact us in case you have further articles to share your experience with the EMSOS community.

Links

Stevenson et al., Mortality of high-risk orthopaedic oncology patients during the COVID-19 pandemic: A prospective cohort study. J Surg Oncol. 2020
https://pubmed.ncbi.nlm.nih.gov/32668015/

Thaler M et al., Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours. Int Orthop. 2020
https://pubmed.ncbi.nlm.nih.gov/32451657/

Schneider KN, Correa-Martínez CL, Gosheger G, Rickert C, Schorn D, Mellmann A, Schwierzeck V, Kampmeier S. Assessing the spreading potential of an undetected case of COVID-19 in orthopaedic surgery. Arch Orthop Trauma Surg. 2020 Jun 10:1–7. doi: 10.1007/s00402-020-03516-1. PMID: 32524227; PMCID: PMC7283422.
https://pubmed.ncbi.nlm.nih.gov/32524227/


Print   Email